Additional file 3: of ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
journal contributionposted on 2018-08-06, 05:00 authored by Sai Ma, Chen-Chen Lu, Li-Yan Yang, Juan-Juan Wang, Bo-Shi Wang, Hong-Qing Cai, Jia-Jie Hao, Xin Xu, Yan Cai, Yu Zhang, Ming-Rong Wang
Figure S2. The effect of ANXA2 knockdown on cell proliferation. KYSE30 and KYSE150 cells were transiently transfected with ANXA2 siRNA or control non-silencing siRNA. Cell viability were assessed using CCK8 assay. (PDF 234 kb).